The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-phenyl-6-(2-propoxyphenyl)-5H-pyrazolo[3,4-d]pyrimidin-4-one ID: ALA4800568
PubChem CID: 162676885
Max Phase: Preclinical
Molecular Formula: C20H18N4O2
Molecular Weight: 346.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCOc1ccccc1-c1nc2c(cnn2-c2ccccc2)c(=O)[nH]1
Standard InChI: InChI=1S/C20H18N4O2/c1-2-12-26-17-11-7-6-10-15(17)18-22-19-16(20(25)23-18)13-21-24(19)14-8-4-3-5-9-14/h3-11,13H,2,12H2,1H3,(H,22,23,25)
Standard InChI Key: ZUAADXSMJLYEGA-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
10.2340 -13.5228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9482 -13.1121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6585 -13.5265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6585 -14.3489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9465 -14.7589 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2340 -14.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4482 -14.6079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9640 -13.9363 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4483 -13.2690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2331 -15.4027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8169 -15.9911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6057 -16.7821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8065 -16.9973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2252 -16.4192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4334 -15.6191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3724 -14.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0865 -14.3491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8009 -14.7618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8009 -15.5848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0891 -15.9972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3724 -15.5900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0865 -13.5222 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8046 -13.1089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8046 -12.2820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5185 -11.8686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9482 -12.2894 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
5 4 2 0
6 5 1 0
1 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
1 9 1 0
10 7 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
10 15 1 0
16 4 1 0
17 16 2 0
18 17 1 0
19 18 2 0
20 19 1 0
21 20 2 0
16 21 1 0
17 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
2 26 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.39Molecular Weight (Monoisotopic): 346.1430AlogP: 3.56#Rotatable Bonds: 5Polar Surface Area: 72.80Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.88CX Basic pKa: ┄CX LogP: 3.52CX LogD: 3.51Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.60Np Likeness Score: -1.57
References 1. Shaaban MA,Elshaier YAMM,Hammad AH,Farag NA,Hassan Haredy H,AbdEl-Ghany AA,Mohamed KO. (2020) Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors., 30 (16): [PMID:32631538 ] [10.1016/j.bmcl.2020.127337 ]